This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
We do not have any donee information for the donee University of California, San Francisco in our system.
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 132 | 349,985 | 1,534,144 | -500,000 | 100,000 | 100,000 | 150,000 | 240,000 | 349,985 | 563,068 | 900,011 | 1,999,696 | 3,609,195 | 29,017,510 |
| Global health | 98 | 349,985 | 1,846,717 | -500,000 | 80,000 | 100,000 | 111,128 | 197,478 | 349,985 | 574,999 | 997,235 | 2,999,544 | 3,986,535 | 29,017,510 |
| Developmental Disabilities | 7 | 240,000 | 207,143 | 10,000 | 10,000 | 120,000 | 240,000 | 240,000 | 240,000 | 240,000 | 240,000 | 300,000 | 300,000 | 300,000 |
| Global development | 2 | 24,978 | 765,002 | 24,978 | 24,978 | 24,978 | 24,978 | 24,978 | 24,978 | 1,505,026 | 1,505,026 | 1,505,026 | 1,505,026 | 1,505,026 |
| Science and Technology | 1 | 97,741 | 97,741 | 97,741 | 97,741 | 97,741 | 97,741 | 97,741 | 97,741 | 97,741 | 97,741 | 97,741 | 97,741 | 97,741 |
| Family planning | 5 | 403,302 | 398,230 | 100,000 | 100,000 | 100,000 | 156,222 | 156,222 | 403,302 | 403,302 | 574,999 | 574,999 | 756,629 | 756,629 |
| Digital Technology | 1 | 101,858 | 101,858 | 101,858 | 101,858 | 101,858 | 101,858 | 101,858 | 101,858 | 101,858 | 101,858 | 101,858 | 101,858 | 101,858 |
| Nutrition | 3 | 383,429 | 677,810 | 150,011 | 150,011 | 150,011 | 150,011 | 383,429 | 383,429 | 383,429 | 1,499,989 | 1,499,989 | 1,499,989 | 1,499,989 |
| Science | 8 | 300,000 | 950,501 | 179,317 | 179,317 | 249,691 | 250,000 | 300,000 | 300,000 | 575,000 | 1,050,000 | 2,500,000 | 2,500,000 | 2,500,000 |
| Health | 4 | 461,358 | 1,093,542 | 247,382 | 247,382 | 247,382 | 461,358 | 461,358 | 461,358 | 1,603,712 | 1,603,712 | 2,061,716 | 2,061,716 | 2,061,716 |
| Biosecurity and pandemic preparedness | 1 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 |
| Scientific research | 2 | 825,000 | 923,159 | 825,000 | 825,000 | 825,000 | 825,000 | 825,000 | 825,000 | 1,021,318 | 1,021,318 | 1,021,318 | 1,021,318 | 1,021,318 |
| Donor | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2004 | 2001 | 1999 | 1996 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 186,532,858.70 | 6,242,113.74 | 4,272,227.00 | 33,032,042.00 | 9,938,823.49 | 43,876,326.00 | 19,117,718.00 | 30,924,407.00 | 2,632,448.00 | 10,679,769.00 | 5,915,740.47 | 12,218,647.00 | 7,682,597.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Chan Zuckerberg Initiative (filter this donee) | 7,304,008.00 | 7,304,008.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Arnold Ventures (filter this donee) | 4,471,909.00 | 0.00 | 3,912,810.00 | 97,741.00 | 0.00 | 0.00 | 461,358.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Open Philanthropy (filter this donee) | 2,346,318.00 | 1,521,318.00 | 825,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| John Merck Fund (filter this donee) | 1,450,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10,000.00 | 0.00 | 300,000.00 | 300,000.00 | 240,000.00 | 240,000.00 | 240,000.00 | 120,000.00 |
| Sloan Foundation (filter this donee) | 401,858.00 | 0.00 | 0.00 | 101,858.00 | 0.00 | 0.00 | 300,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 202,506,951.70 | 15,067,439.74 | 9,010,037.00 | 33,231,641.00 | 9,938,823.49 | 43,876,326.00 | 19,879,076.00 | 30,924,407.00 | 2,632,448.00 | 10,679,769.00 | 5,915,740.47 | 12,228,647.00 | 7,682,597.00 | 300,000.00 | 300,000.00 | 240,000.00 | 240,000.00 | 240,000.00 | 120,000.00 |
| Title (URL linked) | Publication date | Author | Publisher | Affected donors | Affected donees | Affected influencers | Document scope | Cause area | Notes |
|---|---|---|---|---|---|---|---|---|---|
| A Research Funder Knocks on the NIH's Door Looking for Ideas—And Big Grants Flow | 2018-01-11 | Tate Williams | Inside Philanthropy | Open Philanthropy | Arizona State University University of Notre Dame Rockefeller University University of California, San Francisco | Third-party coverage of donor strategy | Scientific research | The article discusses the Open Philanthropy Project second chance funding program for rejected applicants of the National Institutes of Health transformative R01 program. | |
| The Sandler Way: Where Big Philanthropy Meets the Art of Common Sense | 2015-01-27 | David Callahan | Inside Philanthropy | Sandler Foundation | American Civil Liberties Union ProPublica Center for Responsible Lending American Asthma Foundation University of California, San Francisco Center for American Progress Human Rights Watch Stanford University Center on Budget and Policy Priorities | Third-party coverage of donor strategy | The Inside Philanthropy article discusses the giving strategy of the Sandler Foundation, backed by the wealth of Herb and Marion Sandler that they made by growing and then selling the Golden West Financial Corporation. The article identifies a few key principles of the foundation's giving: (1) focus money where it can make a big difference (in many cases, this leads to the creation of new nonprofits), (2) look for leverage points (i.e., look for cases where spending some money can lead to more resoures from others being allocated and greater long-term results), (3) obsess over due diligence, (4) back great leaders, (5) provide long term general support (in contrast to support tied to a specific program area) | ||
| Self-Made Philanthropists | 2008-03-09 | Joe Nocera | New York Times | Sandler Foundation | Human Rights Watch American Civil Liberties Union Acorn Center for Responsible Lending Center for American Progress ProPublica University of California, San Francisco | Third-party coverage of donor strategy | The New York Times Magazine article discusses the giving of couple Herb and Marion Sandler, who made a fortune off of Golden West Financial Corporation, a savings and loan operation in California. The couple began their giving in the 1980s, first as individual donors and then through the Sandler Foundation which they created. Key distinguishing features of the foundation, as highlighted in the article include: a "philanthrocapitalist" approach that relies on extensive vetting of nonprofits before making long, multi-year commitments to them, financing the creation of new nonprofits if necessary, and close engagement with grantees |
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 132) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 383,429.00 | 63 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the Common Application System m-health intervention, generate evidence and provide feedback for the implementation and scale-up of the program; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 109,615.00 | 99 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to use a novel animal model to determine the relative attenuation phenotype or immunogenicity of new oral polio vaccine (OPV) viruses including those made by the consortium for a new OPV-2 as benchmarked against virus Sabin-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,041,281.00 | 18 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to advance malaria elimination in priority regions of southern Africa and the Asia Pacific, and support the global goal of malaria eradication, through evidence generation, technical assistance, resource mobilization and capacity building; Aid type: Other technical assistance. Affected regions: South of Sahara|South & Central Asia. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to improve the quality of patient-centered care for maternal and neonatal health and post-partum family planning among urban, poor women in Uttar Pradesh, India and East Africa; Aid type: Project-type interventions. Affected countries: India|Kenya. | |
| Open Philanthropy | 1,021,318.00 | 36 | Scientific research | https://www.openphilanthropy.org/focus/scientific-research/miscellaneous/university-of-california-san-francisco-chronic-pain-research | Chris Somerville Heather Youngs | Grant over three years to support basic research on understanding the brain mechanisms that process pain messages and that contribute to the transition from acute to chronic pain after injury. The work will be led by Allan Basbaum, PhD, Professor and Chair of UCSF’s Department of Anatomy. This grant will allow UCSF to pursue an answer to the question of how the brain interprets various types of pain signals (e.g., heat, cold, mechanical) and itch, how these signals are regulated by different anesthetics and how they are altered when there is injury. Resolving these questions could facilitate the design of novel drugs that can block pain without also blocking consciousness. Announced: 2018-09-21. | |
| Bill and Melinda Gates Foundation | 172,091.00 | 86 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to allow broad evaluation of available compounds that can be used in mass drug administration programs to kill adult filarial worms (a macrofilaricide) that cause Onchocerciasis and Lymphatic Filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -289,423.00 | 131 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to contribute to a measurable and sustainable reduction in maternal and neonatal morbidity and mortality in Bihar, India; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 43,413.45 | 124 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | To improve the quality of obstetric and neonatal care through mentoring and simulation training in Bihar and Uttar Pradesh; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 144,711.50 | 94 | Global health/Health personnel development | https://iatiregistry.org/publisher/bmgf | -- | To improve the quality of obstetric and neonatal care through mentoring and simulation training in Bihar and Uttar Pradesh; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 101,298.05 | 101 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | To improve the quality of obstetric and neonatal care through mentoring and simulation training in Bihar and Uttar Pradesh; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | -852.26 | 129 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to expand the existing specimen and data repository created by the Consortium for the Performance and Evaluation of HIV Incidence Assays (CEPHIA); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Open Philanthropy | 500,000.00 | 57 | Biosecurity and pandemic preparedness/Scientific research | https://www.openphilanthropy.org/focus/scientific-research/miscellaneous/ucsf-research-antiviral-activity-hsp90-inhibitors | Chris Somerville Heather Youngs | Grant to support research led by Dr. Raul Andino to test the broad spectrum antiviral potential of several drugs. The grant will allow Dr. Andino to carry out tests of the effectiveness of two commercial-quality drugs against five different viruses. Original grant amount of $320,000 in February 2018, and an additional $180,000 added in June 2018 (grant page updated around 2018-06-29). Announced: 2018-03-24. | |
| Bill and Melinda Gates Foundation | 2,436,550.00 | 25 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to define the role of mass azithromycin treatments as an intervention for reducing childhood morbidity and mortality; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Chan Zuckerberg Initiative | 575,000.00 | 50 | Science | https://chanzuckerberg.com/grants-ventures/grants/ | -- | Program: Human Cell Atlas. Grant period: 2018–2019. This grant supports the development of methods for permanently recording cell state changes in DNA in a compact manner that can be read out in single cell format using droplet-based single cell RNA-seq. (PI: Jonathan Weissman). | |
| Chan Zuckerberg Initiative | 179,317.00 | 85 | Science | https://chanzuckerberg.com/grants-ventures/grants/ | -- | Program: Human Cell Atlas. Grant period: 2018–2019. This grant supports the development and incorporation of machine learning algorithms for segmentation of cellular organelles into the soft x-ray tomography pipeline and generate images of segmented cells for the Human Cell Atlas. (PI: Carolyn Larabell, Human Cell Atlas Computational Tools RFA). | |
| Chan Zuckerberg Initiative | 250,000.00 | 77 | Science | https://chanzuckerberg.com/grants-ventures/grants/ | -- | Program: Human Cell Atlas. Grant period: 2018–2019. This grant supports the use multiplexed single cell RNA-sequencing to construct a provisional version of the Human Immune Census across three ethnicities and to develop a new suite of computational tools to analyze the resulting data. (PI: Jimmie Ye, Human Cell Atlas Computational Tools RFA). | |
| Chan Zuckerberg Initiative | 249,691.00 | 78 | Science | https://chanzuckerberg.com/grants-ventures/grants/ | -- | Program: Human Cell Atlas. Grant period: 2018–2019. This grant supports the building and contribution to a set of tools to address the analysis of single cell RNAseq data using the popular Cytoscape network analysis ecosystem. (PI: John Morris, Human Cell Atlas Computational Tools RFA). | |
| Chan Zuckerberg Initiative | 2,500,000.00 | 23 | Science | https://chanzuckerberg.com/grants-ventures/grants/ | -- | Program: Neurodegeneration Challenge Network. Grant period: 2018–2023. This grant supports using machine learning and systems pharmacology methods to characterize novel bioactive small molecules able to control cellular processes underlying proteinopathies. (PI: Michael Keiser, Early Career Award). | |
| Chan Zuckerberg Initiative | 2,500,000.00 | 23 | Science | https://chanzuckerberg.com/grants-ventures/grants/ | -- | Program: Neurodegeneration Challenge Network. Grant period: 2018–2023. This grant supports leveraging a CRISPR-based functional genomics platform in human iPSC-derived neurons and glia to elucidate cellular mechanisms of neurodegenerative diseases. (PI: Martin Kampmann, Early Career Award). | |
| Chan Zuckerberg Initiative | 1,050,000.00 | 35 | Science | https://chanzuckerberg.com/grants-ventures/grants/ | -- | Program: Neurodegeneration Challenge Network. Grant period: 2018–2021. This grant supports bridging the pathophysiological knowledge gap between human genetic risk pathways and neuropathological findings through deep, systematic phenotyping of a set of human fibroblast, induced neuron, and post-mortem tissue resources all derived from the same individual patients. (PI: William Seeley, Collaborative Science Award). | |
| Bill and Melinda Gates Foundation | 167,626.00 | 87 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop a prototype system into a decision framework forming the basis of the surveillance and response systems necessary to achieve malaria elimination in Swaziland and Zimbabwe; Aid type: Project-type interventions. Affected countries: Zimbabwe|Eswatini. | |
| Bill and Melinda Gates Foundation | 80,000.00 | 121 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to use a novel animal model to determine the relative attenuation phenotype or immunogenicity of new oral polio vaccine (OPV) viruses including those made by the consortium for a new OPV-2 as benchmarked against virus Sabin-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 468,118.00 | 59 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to advance malaria elimination in priority regions of southern Africa and the Asia Pacific, and support the global goal of malaria eradication, through evidence generation, technical assistance, resource mobilization and capacity building; Aid type: Other technical assistance. Affected regions: South of Sahara|South & Central Asia. | |
| Bill and Melinda Gates Foundation | 111,128.00 | 98 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to perform research relevant to implementation of new adherence interventions for improving tuberculosis treatment completion rates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 448,237.00 | 61 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to allow broad evaluation of available compounds that can be used in mass drug administration programs to kill adult filarial worms (a macrofilaricide) that cause Onchocerciasis and Lymphatic Filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 330,102.15 | 68 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | To improve the quality of obstetric and neonatal care through mentoring and simulation training in Bihar and Uttar Pradesh; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 1,100,340.50 | 34 | Global health/Health personnel development | https://iatiregistry.org/publisher/bmgf | -- | To improve the quality of obstetric and neonatal care through mentoring and simulation training in Bihar and Uttar Pradesh; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 770,238.35 | 45 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | To improve the quality of obstetric and neonatal care through mentoring and simulation training in Bihar and Uttar Pradesh; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 296,426.00 | 75 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop a prototype system into a decision framework forming the basis of the surveillance and response systems necessary to achieve malaria elimination in Swaziland and Zimbabwe; Aid type: Project-type interventions. Affected countries: Zimbabwe|Eswatini. | |
| Bill and Melinda Gates Foundation | 350,000.00 | 65 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to use a novel animal model to determine the relative attenuation phenotype or immunogenicity of new oral polio vaccine (OPV) viruses including those made by the consortium for a new OPV-2 as benchmarked against virus Sabin-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 150,011.00 | 92 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the Common Application System m-health intervention, generate evidence and provide feedback for the implementation and scale-up of the program; Aid type: Project-type interventions. Affected countries: India. | |
| Open Philanthropy | 825,000.00 | 41 | Scientific research/transformative R01 | https://www.openphilanthropy.org/focus/scientific-research/miscellaneous/ucsf-liver-regeneration-experiments | Chris Somerville | Grant over three years to the University of California, San Francisco (UCSF) to support research into the development of a stem cell treatment method for repairing or replacing damaged human livers. The work will be led by Tammy T. Chang, MD, PhD, assistant professor in the UCSF Department of Surgery. Part of a set of "second chance" grants by the Open Philanthropy Project for some rejected applications for the NIH Transformative R01 program https://commonfund.nih.gov/tra discussed at https://www.openphilanthropy.org/blog/our-second-chance-program-nih-transformative-research-applicants and https://www.nature.com/articles/d41586-017-08795-0. Announced: 2017-12-20. | |
| Arnold Ventures | 247,382.00 | 79 | Health | https://www.arnoldventures.org/grants/ | -- | To analyze data and develop resources to help institutions adopt sugar-sweetened beverage sales bans. Affected states: California. | |
| Arnold Ventures | 1,603,712.00 | 29 | Health | https://www.arnoldventures.org/grants/ | -- | To support the development an electronic archive of documents related to the sugar industry that will help advance research in nutrition science. Affected states: California. | |
| Arnold Ventures | 2,061,716.00 | 26 | Health | https://www.arnoldventures.org/grants/ | -- | To analyze the health impacts of an institutional sales ban on sugar-sweetened beverages. Affected states: California. | |
| Bill and Melinda Gates Foundation | 302,351.00 | 70 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to improve the quality of patient-centered care for maternal and neonatal health and post-partum family planning among urban, poor women in Uttar Pradesh, India and East Africa; Aid type: Project-type interventions. Affected countries: India|Kenya. | |
| Bill and Melinda Gates Foundation | 29,017,510.00 | 1 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to advance malaria elimination in priority regions of southern Africa and the Asia Pacific, and support the global goal of malaria eradication, through evidence generation, technical assistance, resource mobilization and capacity building; Aid type: Other technical assistance. Affected regions: South of Sahara|South & Central Asia. | |
| Bill and Melinda Gates Foundation | 769,995.00 | 46 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to develop a vaginal diaphragm to detect changes in cervical collagen and wirelessly alert health providers before preterm labor begins. This device would identify a new pre-labor “window” during which intervention could reduce mortality and disability re; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 269,982.00 | 76 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to measure Pre-exposure prophylaxis (PrEP) adherence (hair and plasma samples for TDF levels) and to pay the importation taxes in Kenya on donated Truvada from Gilead—all of which will contribute to rigorous study that will provide insights into the deliv; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,499,989.00 | 32 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to evaluate the Common Application System m-health intervention, generate evidence and provide feedback for the implementation and scale-up of the program; Aid type: Project-type interventions. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 121,000.00 | 96 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop an effective and safer poliovirus vaccine to prevent paralytic poliomyelitis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 525,607.50 | 54 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to convene in spring 2016 a diverse group of health, science, and technology experts, from government, academia, and the private sector, to explore how to unlock the full potential of precision public health; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 525,607.50 | 54 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to convene in spring 2016 a diverse group of health, science, and technology experts, from government, academia, and the private sector, to explore how to unlock the full potential of precision public health; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Arnold Ventures | 97,741.00 | 120 | Science and Technology | https://www.arnoldventures.org/grants/ | -- | To help develop a plan for increasing the use of preprints in the life sciences community. Affected states: California. | |
| Sloan Foundation | 101,858.00 | 100 | Digital Technology/Scholarly Communication | https://sloan.org/grant-detail/6691 | -- | Grant investigator: Ronald Vale; to partially fund the planning and piloting of a preprint service for the life sciences. | |
| Bill and Melinda Gates Foundation | 349,984.50 | 66 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to enable a better understanding of the causes of preterm birth by providing more accurate gestational age measures and to identify better methods to track the occurrence and outcomes of preterm birth in the lowest resource settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 349,984.50 | 66 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to enable a better understanding of the causes of preterm birth by providing more accurate gestational age measures and to identify better methods to track the occurrence and outcomes of preterm birth in the lowest resource settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,800,986.00 | 28 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to allow broad evaluation of available compounds that can be used in mass drug administration programs to kill adult filarial worms (a macrofilaricide) that cause Onchocerciasis and Lymphatic Filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 697,107.00 | 48 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to gather and summarize information and recent learning around primary health care and to foster a global coalition of actors who will define a shared vision of the mixed Primary Health Care system of the future; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 789,249.00 | 44 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop a prototype system into a decision framework forming the basis of the surveillance and response systems necessary to achieve malaria elimination in Swaziland and Zimbabwe; Aid type: Project-type interventions. Affected countries: Zimbabwe|Eswatini. | |
| Bill and Melinda Gates Foundation | 403,302.00 | 62 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to develop and execute a plan for the private sector rollout of Sayana Press in Nigeria; Aid type: Project-type interventions. Affected countries: Nigeria. | |
| Bill and Melinda Gates Foundation | 824,999.00 | 42 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify biological transmission links between individuals infected with malaria; Aid type: Project-type interventions. Affected regions: South of Sahara; affected countries: Mozambique|Eswatini|Namibia. | |
| Bill and Melinda Gates Foundation | 24,978.00 | 126 | Global development/Promotion of development awareness (non-sector allocable) | https://iatiregistry.org/publisher/bmgf | -- | to support the Commission on Investing in Health to make the case for investing in health within specific Donor, Low-Income and Middle-Income Countries; Aid type: Development awareness. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,344,212.00 | 7 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to improve the quality of patient-centered care for maternal and neonatal health and post-partum family planning among urban, poor women in Uttar Pradesh, India and East Africa; Aid type: Project-type interventions. Affected countries: India|Kenya. | |
| Bill and Melinda Gates Foundation | 379,000.00 | 64 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to use a novel animal model to determine the relative attenuation phenotype or immunogenicity of new oral polio vaccine (OPV) viruses including those made by the consortium for a new OPV-2 as benchmarked against virus Sabin-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -24,978.51 | 130 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to promote adoption of “a grand convergence in global health” as the Sustainable Development Goal for the health sector, through modeling the health outcomes that could be achieved by 2030, developing a roadmap for implementation of the convergence agenda; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,971,424.00 | 11 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to test the hypothesis that addition of blockade of type I interferon (IFN) activity to anti-retroviral therapy (ART) will facilitate immune-mediated clearance of human immunodeficiency virus (HIV), allowing for elite control off of ART; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,584,024.00 | 15 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to contribute to a measurable and sustainable reduction in maternal and neonatal morbidity and mortality in Bihar, India; Aid type: Other technical assistance. Affected countries: India. | |
| Bill and Melinda Gates Foundation | 4,788,458.00 | 6 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support Vietnam to build the necessary evidence, tools, strategies and partnerships to accelerate progress and achieve elimination of Plasmodium falciparum malaria by 2020; Aid type: Project-type interventions. Affected countries: Viet nam. | |
| Bill and Melinda Gates Foundation | 163,431.00 | 88 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to test the potential efficacy for enhancing autophagy activation during Mycobacterium tuberculosis infection and to evaluate if the newly-discovered autophagy agonist, DMXAA, will promote Mycobacterium tuberculosis clearance and synergize with antibiotic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 77,025.00 | 123 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to use a novel animal model to determine the relative attenuation phenotype or immunogenicity of new oral polio vaccine (OPV) viruses including those made by the consortium for a new OPV-2 as benchmarked against virus Sabin-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,212,021.00 | 9 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop and test new malaria elimination strategies and tools. Accelerating progress towards malaria eradication: working across global, regional, and national levels, and through operational research, to shrink the malaria map. Investment start date: ; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,505,026.00 | 30 | Global development/Promotion of development awareness (non-sector allocable) | https://iatiregistry.org/publisher/bmgf | -- | to support the Commission on Investing in Health to make the case for investing in health within specific Donor, Low-Income and Middle-Income Countries; Aid type: Development awareness. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to calculate gestational age in weeks of newborns by developing an algorithm derived from metabolic markers taken during routine screenings to help monitor brain-related functions and development in infants whose gestational age is unknown; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 150,000.00 | 93 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to study and understand the trends in key maternal and child health indicators, as well as the unique determinants of maternal health outcomes in urban settings; Aid type: Project-type interventions. Affected regions: Africa|Asia. | |
| Bill and Melinda Gates Foundation | -83.00 | 128 | Global health/Health education | https://iatiregistry.org/publisher/bmgf | -- | to establish the Consortium of Universities for Global Health (CUGH) as a self-sustaining organization representing North American university-based global health programs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 25,000,000.00 | 2 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to contribute to a measurable and sustainable reduction in the burden of preterm birth (PTB); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 325,000.00 | 69 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to promote adoption of “a grand convergence in global health” as the Sustainable Development Goal for the health sector, through modeling the health outcomes that could be achieved by 2030, developing a roadmap for implementation of the convergence agenda; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 15,438,584.00 | 3 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop and test new malaria elimination strategies and tools. Accelerating progress towards malaria eradication: working across global, regional, and national levels, and through operational research, to shrink the malaria map. Investment start date: ; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 2,695,855.00 | 21 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to develop a vaginal diaphragm to detect changes in cervical collagen and wirelessly alert health providers before preterm labor begins. This device would identify a new pre-labor “window” during which intervention could reduce mortality and disability re; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to better monitor the effect of drugs on parasitic worm infections by developing a cheap electromagnetic detector incorporated into a bandage to simply and non-invasively monitor parasite viability.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify new drugs that destroy adult filarid parasitic worms by genetically engineering the related free-living and genetically tractable model nematode Caenorhabditis elegans to carry an essential parasite gene, and using it for drug screens.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to use a novel animal model to determine the relative attenuation phenotype or immunogenicity of new oral polio vaccine (OPV) viruses including those made by the consortium for a new OPV-2 as benchmarked against virus Sabin-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 683,279.00 | 49 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to study and understand the trends in key maternal and child health indicators, as well as the unique determinants of maternal health outcomes in urban settings; Aid type: Project-type interventions. Affected regions: Africa|Asia. | |
| Arnold Ventures | 461,358.00 | 60 | Health | https://www.arnoldventures.org/grants/ | -- | To educate the public about sugar and its impact on health. Affected states: California. | |
| Sloan Foundation | 300,000.00 | 71 | Science/Microbiology of the Built Environment | https://sloan.org/grant-detail/7780 | -- | Grant investigator: Susan Lynch; to examine the house dust fungal microbiome. | |
| Bill and Melinda Gates Foundation | 4,324,791.00 | 8 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to allow broad evaluation of available compounds that can be used in mass drug administration programs to kill adult filarial worms (a macrofilaricide) that cause Onchocerciasis and Lymphatic Filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,000,000.00 | 19 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to create a partnership to fight neglected infectious disease in Mesoamerica. Fighting Infections through Research, Science and Technology (FIRST) Phase I and II: Creating a Partnership to Fight Neglected Infectious Disease in Mesoamerica. Investment star; Aid type: Project-type interventions. Affected regions: North & Central America. | |
| Bill and Melinda Gates Foundation | 509,976.54 | 56 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to establish the basis for effective and large-scale engagement of PPMVs to improve management of childhood diarrhea, pneumonia and malaria in Nigeria; Aid type: Project-type interventions. Affected countries: Nigeria. | |
| Bill and Melinda Gates Foundation | 989,954.46 | 39 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to establish the basis for effective and large-scale engagement of PPMVs to improve management of childhood diarrhea, pneumonia and malaria in Nigeria; Aid type: Project-type interventions. Affected countries: Nigeria. | |
| Bill and Melinda Gates Foundation | 14,854,765.00 | 4 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to define the role of mass azithromycin treatments as an intervention for reducing childhood morbidity and mortality; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 156,221.50 | 90 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support research on integration of Family Planning into HIV care in Nyanza Province, Kenya; Aid type: Project-type interventions. Affected countries: Kenya. | |
| Bill and Melinda Gates Foundation | 156,221.50 | 90 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support research on integration of Family Planning into HIV care in Nyanza Province, Kenya; Aid type: Project-type interventions. Affected countries: Kenya. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to generate apicoplast-free P. falciparum parasites to identify anti-malarial compounds that specifically target this organelle, which is essential for malaria parasite survival.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 2,687,691.00 | 22 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to gather, analyze, and disseminate evidence on malaria elimination and to synthesize new evidence into practical guidance for strategic planning and decision making at global, regional, and country levels; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 3,324,161.00 | 16 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to expand the existing specimen and data repository created by the Consortium for the Performance and Evaluation of HIV Incidence Assays (CEPHIA); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 820,625.00 | 43 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to demonstrate the efficacy of the non-pneumatic anti-shock garment to decrease maternal mortality and morbidity associated with obstetric hemorrhage among women in Zambia and Zimbabwe; Aid type: Project-type interventions. Affected countries: Zambia|Zimbabwe. | |
| Bill and Melinda Gates Foundation | 756,629.00 | 47 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to increase financial and policy support for the discovery and development of new and adaptive contraceptive technologies, ultimately leading to accelerated contraceptive uptake and improved access to high quality family planning options worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 999,215.00 | 37 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to gather, analyze, and disseminate evidence on malaria elimination and to synthesize new evidence into practical guidance for strategic planning and decision making at global, regional, and country levels; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to convene an International Stakeholders’ meeting on the Integration of Family Planning and HIV/AIDS in Kenya; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to convene an International Stakeholders’ meeting on the Integration of Family Planning and HIV/AIDS in Kenya; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -500,000.00 | 132 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide evidence-based analysis and provide policy options to the global health community on priority topics in global public health; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to develop a vaginal diaphragm to detect changes in cervical collagen and wirelessly alert health providers before preterm labor begins.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 79,369.00 | 122 | Global health/Health education | https://iatiregistry.org/publisher/bmgf | -- | to provide a forum for implementers to share experience and research about the franchising of private healthcare providers to support the delivery of priority public health services; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 997,235.00 | 38 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to design an effective vaccine against HIV: An Alternative Hypothesis. GCE Phase II: Design of an Effective Vaccine against HIV: An Alternative Hypothesis. Investment start date: 4/5/2011 to end date: 3/31/2014. Grantee name: University of California San ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,609,195.00 | 14 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to allow broad evaluation of available compounds that can be used in mass drug administration programs to kill adult filarial worms (a macrofilaricide) that cause Onchocerciasis and Lymphatic Filariasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop a new drug delivery technology that exploits the high ferrous iron concentrations in malaria parasites; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,499,993.00 | 31 | Global health/Health education | https://iatiregistry.org/publisher/bmgf | -- | to establish the Consortium of Universities for Global Health (CUGH) as a self-sustaining organization representing North American university-based global health programs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,270,581.00 | 5 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to gather, analyze, and disseminate evidence on malaria elimination and to synthesize new evidence into practical guidance for strategic planning and decision making at global, regional, and country levels; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify a natural viral pathogen that can be used to kill nematodes that cause a wide variety of diseases in humans; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to use mathematical models and cross-sectional survey data to determine the minimum number of people in a community who need to be treated for trachoma in order to halt transmission of the disease.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500,000.00 | 57 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to identify the polypeptide(s) that mediates CAF activity through proteomic analysis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 563,068.00 | 53 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to demonstrate the efficacy of the non-pneumatic anti-shock garment to decrease maternal mortality and morbidity associated with obstetric hemorrhage among women in Zambia and Zimbabwe; Aid type: Project-type interventions. Affected countries: Zambia|Zimbabwe. | |
| Bill and Melinda Gates Foundation | 3,205,513.47 | 17 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to provide evidence-based analysis and provide policy options to the global health community on priority topics in global public health; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 574,999.00 | 51 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support research on integration of Family Planning into HIV care in Nyanza Province, Kenya; Aid type: Project-type interventions. Affected countries: Kenya. | |
| Bill and Melinda Gates Foundation | 574,999.00 | 51 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to support research on integration of Family Planning into HIV care in Nyanza Province, Kenya; Aid type: Project-type interventions. Affected countries: Kenya. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to test the theory that HIV proteins, nucleic acids and antibodies to HIV can be detected in shafts of hair, possibly providing a low-cost tool to determine the timing of HIV infection, which is essential for measuring incident rates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to detect parasite transmission networks to focus malaria elimination interventions; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 297,161.00 | 74 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to advocate for global health resources in academic centers, define and develop new programs for training and research in global health, and build the field of global health in academia; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 3,750,270.50 | 12 | Global health/Health personnel development | https://iatiregistry.org/publisher/bmgf | -- | to develop strategies to support African academic institutions to increase the supply of well-trained health professionals and conduct locally-relevant research, thus strengthening their capacity to improve health outcomes; Aid type: Project-type interventions. Affected countries: Tanzania, united republic of. | |
| Bill and Melinda Gates Foundation | 3,750,270.50 | 12 | Global health/Medical education/training | https://iatiregistry.org/publisher/bmgf | -- | to develop strategies to support African academic institutions to increase the supply of well-trained health professionals and conduct locally-relevant research, thus strengthening their capacity to improve health outcomes; Aid type: Project-type interventions. Affected countries: Tanzania, united republic of. | |
| Bill and Melinda Gates Foundation | 140,180.00 | 95 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the study the applicability of the Aravind Eye care model for scale up for Male Circumcision in Africa; Aid type: Project-type interventions. Affected regions: Africa. | |
| Bill and Melinda Gates Foundation | 31,952.00 | 125 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support planning meetings and convene an inaugural organizing meeting to establish a consortium of North American university based programs involved in global health education, research, and training; Aid type: Other technical assistance. Affected countries: United states of america (the). | |
| Bill and Melinda Gates Foundation | 3,986,535.00 | 10 | Global health/Medical education/training | https://iatiregistry.org/publisher/bmgf | -- | to create a successful University of California School of Global Health that sparks new momentum and excitement in global health, both in the University of California and the global community; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to study augmentation of GI tract defenses to protect against HIV disease. A Grand Challenges Explorations grant to study augmentation of GI tract defenses to protect against HIV disease.. Investment start date: 10/1/2008 to end date: 3/31/2010. Grantee n; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to research whether building tolerance to HIV will hinder disease progression better than vaccinations that activate the immune system and trigger HIV activity.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to test his hypothesis that APOBEC proteins, which have been found to restrict replication of HIV, can be used to as an immunogen to stimulate a T cell response which would act against HIV infected cells.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 102 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to engineer naturally occurring erythrotropic bacteria to target malaria infected red blood cells to serve as a potential prophylactic and treatment for malaria in humans.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 159,439.00 | 89 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to support planning meetings and convene an inaugural organizing meeting to establish a consortium of North American university based programs involved in global health education, research, and training; Aid type: Other technical assistance. Affected countries: United states of america (the). | |
| John Merck Fund | 10,000.00 | 127 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramTo support research by John Merck Scholar finalist Susan Voglmaier on the developmental regulation of glutamate release in cells and circuits. | |
| Bill and Melinda Gates Foundation | 1,387,002.00 | 33 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to demonstrate the efficacy of the non-pneumatic anti-shock garment to decrease maternal mortality and morbidity associated with obstetric hemorrhage among women in Zambia and Zimbabwe; Aid type: Project-type interventions. Affected countries: Zambia|Zimbabwe. | |
| Bill and Melinda Gates Foundation | 197,478.00 | 84 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to convene an international symposium to define the new field of Global Health. Global Health Sustainability: Focusing on the Workforce and Follow-up Programs. Investment start date: 9/3/2007 to end date: 3/3/2008. Grantee name: University of California S; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 198,866.00 | 83 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to convene an international conference on increasing access to surgery in resource-constrained settings in sub-Saharan Africa; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| Bill and Melinda Gates Foundation | 1,999,696.00 | 27 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | for general operating support for the Global Health Group. The Global Health Group: From Analysis to Action. Investment start date: 10/1/2007 to end date: 5/1/2011. Grantee name: University of California San Francisco; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified|South of Sahara. | |
| Bill and Melinda Gates Foundation | 2,999,544.00 | 20 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | for general operating support for the Global Health Group. The Global Health Group: From Analysis to Action. Investment start date: 10/1/2007 to end date: 5/1/2011. Grantee name: University of California San Francisco; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified|South of Sahara. | |
| Bill and Melinda Gates Foundation | 900,011.00 | 40 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to create an information resource that will accelerate the identification and prioritization of drug targets for creation of antibiotics that kill persistent M. tuberculosis bacteria; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| John Merck Fund | 300,000.00 | 71 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramTo support research on the neural correlates of learning in the hippocampal-cortical circuit by John Merck Scholar Loren Frank. | |
| John Merck Fund | 300,000.00 | 71 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramTo support research by John Merck Scholar Samuel Pleasure on developmental signaling systems in hippocampal development. | |
| John Merck Fund | 240,000.00 | 80 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramTo support research on trans-synaptic signaling molecules and mechanisms that generate synaptic specificity during the development of the nervous system. | |
| John Merck Fund | 240,000.00 | 80 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramResearch on the development of song learning in birds. | |
| John Merck Fund | 240,000.00 | 80 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramResearch on the characterization of the structure and function of Tes-1, a homeobox-containing gene expressed in the embryonic forebrain. | |
| John Merck Fund | 120,000.00 | 97 | Developmental Disabilities | https://www.jmfund.org/program-grants/ | -- | Focus: John Merck Scholars I ProgramTo support research by Gregory MacDonald, MD. |